BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17420970)

  • 21. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
    Emond V; Joyal C; Poissant H
    Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of the vascular basal lamina in the cerebral cortex in drug abuse: a combined morphometric and immunohistochemical investigation.
    Büttner A; Kroehling C; Mall G; Penning R; Weis S
    Drug Alcohol Depend; 2005 Jul; 79(1):63-70. PubMed ID: 15943945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.
    Gillespie NA; Neale MC; Prescott CA; Aggen SH; Kendler KS
    Addiction; 2007 Jun; 102(6):920-30. PubMed ID: 17523987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene.
    Schilt T; Koeter MW; de Win MM; Zinkstok JR; van Amelsvoort TA; Schmand B; den Brink Wv
    Eur Neuropsychopharmacol; 2009 Feb; 19(2):116-24. PubMed ID: 19042106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units].
    Chrostek Maj J; Kroch S; Kamenczak A; Polewka A; Szerszeń-Motyka J
    Przegl Lek; 2004; 61(4):317-9. PubMed ID: 15521592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance abusers' self-awareness of the neurobehavioral consequences of addiction.
    Verdejo-García A; Pérez-García M
    Psychiatry Res; 2008 Mar; 158(2):172-80. PubMed ID: 18237786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Information processing speed in ecstasy (MDMA) users.
    Wareing M; Fisk JE; Montgomery C; Murphy PN; Chandler MD
    Hum Psychopharmacol; 2007 Mar; 22(2):81-8. PubMed ID: 17295197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential impact of severity of drug use on frontal behavioral symptoms.
    Verdejo-García A; Rivas-Pérez C; López-Torrecillas F; Pérez-García M
    Addict Behav; 2006 Aug; 31(8):1373-82. PubMed ID: 16326022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
    de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
    Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.
    Peters F; Collette F; Degueldre C; Sterpenich V; Majerus S; Salmon E
    Brain; 2009 Jul; 132(Pt 7):1833-46. PubMed ID: 19433442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Brain mechanisms involved in decision-making].
    Martínez-Selva JM; Sánchez-Navarro JP; Bechara A; Román F
    Rev Neurol; 2006 Apr 1-15; 42(7):411-8. PubMed ID: 16602058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of ventromedial prefrontal cortex in addiction disorders].
    Kelemen O; Máttyássy A; Kéri S
    Ideggyogy Sz; 2004 Jan; 57(1-2):4-10. PubMed ID: 15042863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of MDMA and cocaine on inhibitory avoidance and object recognition tests in rodents.
    García-Pardo MP; De la Rubia Ortí JE; Aguilar Calpe MA
    Neurobiol Learn Mem; 2017 Dec; 146():1-11. PubMed ID: 29081371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis, cocaine, and visuomotor integration: evidence for a role of dopamine D1 receptors in binding perception and action.
    Colzato LS; Hommel B
    Neuropsychologia; 2008 Apr; 46(5):1570-5. PubMed ID: 18242650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic studies of drugs of abuse.
    Volkow ND; Fowler JS; Wolf AP; Gillespi H
    NIDA Res Monogr; 1990; 105():47-53. PubMed ID: 1876084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiogenesis in adult rats treated chronically with cocaine during adolescence: effects of extended abstinence and 8-OH-DPAT treatment.
    Santucci AC; Madeira E
    Brain Res Bull; 2008 Jul; 76(4):402-11. PubMed ID: 18502317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unsuspected exposure to cocaine in preschool children from a Mediterranean city detected by hair analysis.
    Joya X; Papaseit E; Civit E; Pellegrini M; Vall O; Garcia-Algar O; Scaravelli G; Pichini S
    Ther Drug Monit; 2009 Jun; 31(3):391-5. PubMed ID: 19333147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.